OBJECTIVES: We measured symptom and influenza prevalence, and the effectiveness of symptom and temperature screening for identifying influenza, in arriving international airline travelers. METHODS: This cross-sectional study collected data from travelers to Christchurch International Airport, New Zealand, in winter 2008, via a health questionnaire, temperature testing, and respiratory sampling. RESULTS: Forms were returned by 15 976 (68%) travelers. Of these, 17% reported at least 1 influenza symptom, with runny or blocked nose (10%) and cough (8%) most common. Respiratory specimens were obtained from 3769 travelers. Estimated prevalence of influenza was 1.1% (4% among symptomatic, 0.2% among asymptomatic). The sensitivity of screening criteria ranged from 84% for "any symptom" to 3% for a fever of 37.8 °C or greater. The positive predictive value was low for all criteria. CONCLUSIONS: Border screening using self-reported symptoms and temperature testing has limitations for preventing pandemic influenza from entering a country. Using "any symptom" or cough would lead to many uninfected people being investigated, yet some infected people would remain undetected. If more specific criteria such as fever were used, most infected people would enter the country despite screening.
OBJECTIVES: We measured symptom and influenza prevalence, and the effectiveness of symptom and temperature screening for identifying influenza, in arriving international airline travelers. METHODS: This cross-sectional study collected data from travelers to Christchurch International Airport, New Zealand, in winter 2008, via a health questionnaire, temperature testing, and respiratory sampling. RESULTS: Forms were returned by 15 976 (68%) travelers. Of these, 17% reported at least 1 influenza symptom, with runny or blocked nose (10%) and cough (8%) most common. Respiratory specimens were obtained from 3769 travelers. Estimated prevalence of influenza was 1.1% (4% among symptomatic, 0.2% among asymptomatic). The sensitivity of screening criteria ranged from 84% for "any symptom" to 3% for a fever of 37.8 °C or greater. The positive predictive value was low for all criteria. CONCLUSIONS: Border screening using self-reported symptoms and temperature testing has limitations for preventing pandemic influenza from entering a country. Using "any symptom" or cough would lead to many uninfected people being investigated, yet some infected people would remain undetected. If more specific criteria such as fever were used, most infected people would enter the country despite screening.
Authors: Timothy M Uyeki; Ramakrishna Prasad; Charles Vukotich; Samuel Stebbins; Charles R Rinaldo; Yu-Hui Ferng; Stephen S Morse; Elaine L Larson; Allison E Aiello; Brian Davis; Arnold S Monto Journal: Clin Infect Dis Date: 2009-05-01 Impact factor: 9.079
Authors: Alasdair R Duncan; Patricia C Priest; Lance C Jennings; Cheryl R Brunton; Michael G Baker Journal: Am J Public Health Date: 2009-10 Impact factor: 9.308
Authors: Michael G Baker; Craig N Thornley; Clair Mills; Sally Roberts; Shanika Perera; Julia Peters; Anne Kelso; Ian Barr; Nick Wilson Journal: BMJ Date: 2010-05-21
Authors: Fabrice Carrat; Elisabeta Vergu; Neil M Ferguson; Magali Lemaitre; Simon Cauchemez; Steve Leach; Alain-Jacques Valleron Journal: Am J Epidemiol Date: 2008-01-29 Impact factor: 4.897
Authors: Benjamin J Cowling; Lincoln L H Lau; Peng Wu; Helen W C Wong; Vicky J Fang; Steven Riley; Hiroshi Nishiura Journal: BMC Infect Dis Date: 2010-03-30 Impact factor: 3.090
Authors: Justin Lessler; Nicholas G Reich; Ron Brookmeyer; Trish M Perl; Kenrad E Nelson; Derek A T Cummings Journal: Lancet Infect Dis Date: 2009-05 Impact factor: 25.071
Authors: Lance C Jennings; Patricia C Priest; Rebecca A Psutka; Alasdair R Duncan; Trevor Anderson; Patalee Mahagamasekera; Andrew Strathdee; Michael G Baker Journal: J Clin Virol Date: 2015-03-14 Impact factor: 3.168
Authors: Ani Movsisyan; Jacob Burns; Renke Biallas; Michaela Coenen; Karin Geffert; Olaf Horstick; Irma Klerings; Lisa Maria Pfadenhauer; Peter von Philipsborn; Kerstin Sell; Brigitte Strahwald; Jan M Stratil; Stephan Voss; Eva Rehfuess Journal: BMJ Open Date: 2021-04-09 Impact factor: 2.692